RPG Life Sciences Limited Financial Statements

RPG Life Sciences Limited (RPGLIFE) reported revenue of ₹7.08B in FY2026 with net income of ₹1.15B. Total assets stood at ₹7.93B. Net worth was ₹6.05B (₹605 Cr) and free cash flow was -₹88.60M.

RPG Life Sciences Limited Income Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Revenue		6.53B	7.08B
Cost of Rev. Cost of Revenue		-2.14B	-2.52B
Gross Profit		4.39B	4.55B
SGA Sales, General & Admin		-2.80B	-1.41B
Op. Income Operating Income		1.38B	1.26B
PBT Profit Before Tax		2.33B	1.54B
Net Income		1.83B	1.15B
Dil. Shares Diluted Shares		16.54M	16.54M
Diluted EPS		110.80	69.64

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows RPG Life Sciences Limited's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

RPG Life Sciences Limited Balance Sheet

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Curr. assets Total current assets		4.65B	5.59B
Non-curr. assets Total non-current assets		1.93B	2.34B
Total assets		6.58B	7.93B
Curr. liabilities Total current liabilities		1.20B	1.61B
Non-curr. liab. Total non-current liabilities		74.50M	272.40M
Total liabilities		1.27B	1.88B
Total equity		5.31B	6.05B
Total liab. & eq. Total liabilities & equity		6.58B	7.93B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures RPG Life Sciences Limited's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

RPG Life Sciences Limited Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Net Income		2.33B	1.54B
Operating CF Cash flow Operating Activities		778.60M	565.00M
Capex Investments in PPE		-360.30M	-653.60M
Investing CF Cash flow Investing Activities		-418.00M	858.40M
Dividend Paid		-264.60M	-396.90M
Financing CF Cash flow Financing Activities		-270.80M	-205.80M
Cash (start) Cash at beginning of period		197.20M	287.00M
Cash (end) Cash at end of period		287.00M	1.50B
FCF Free Cash Flow		418.30M	-88.60M

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how RPG Life Sciences Limited's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2026